The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

They also want to see how today’s diabetes medicines, like GLP-1 agonists (which help the body make more insulin), affect ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to aging, ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Stem cells are often described as the body's master cells. Healthy stem cells can restore the blood system after cancer ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

When analyzing hundreds of single cells from the tumors of two patients with TI-CH, they confirmed that TET2 mutations were mostly present in myeloid cells but not in other immune cell types.

During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

A new study has revealed important differences in how carotid artery narrowing, a major risk factor for stroke, affects men ...

Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...